Vontobel Holding’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368K | Sell |
7,536
-3,320
| -31% | -$162K | ﹤0.01% | 874 |
|
|
2025
Q1 | $553K | Sell |
10,856
-676
| -6% | -$34.4K | ﹤0.01% | 754 |
|
|
2024
Q4 | $521K | Buy |
+11,532
| New | +$521K | ﹤0.01% | 778 |
|
|
2023
Q4 | – | Sell |
-23,513
| Closed | -$527K | – | 1158 |
|
|
2023
Q3 | $527K | Sell |
23,513
-922
| -4% | -$20.7K | ﹤0.01% | 753 |
|
|
2023
Q2 | $994K | Buy |
+24,435
| New | +$994K | 0.01% | 598 |
|
|
2022
Q4 | – | Sell |
-35,425
| Closed | -$1.78M | – | 1114 |
|
|
2022
Q3 | $1.78M | Sell |
35,425
-2,026
| -5% | -$102K | 0.02% | 426 |
|
|
2022
Q2 | $1.51M | Buy |
37,451
+5,770
| +18% | +$233K | 0.02% | 440 |
|
|
2022
Q1 | $1.18M | Sell |
31,681
-1,378
| -4% | -$51.5K | 0.01% | 565 |
|
|
2021
Q4 | $1.32M | Buy |
+33,059
| New | +$1.32M | 0.01% | 557 |
|
|
2021
Q2 | – | Sell |
-23,226
| Closed | -$1.1M | – | 1174 |
|
|
2021
Q1 | $1.1M | Buy |
23,226
+125
| +0.5% | +$5.92K | 0.01% | 510 |
|
|
2020
Q4 | $1.48M | Buy |
+23,101
| New | +$1.48M | 0.01% | 424 |
|